Yahoo! (YHOO) Bidding War for Core Unit; Stifel Eyes Potential In Celator Pharma (CPXX)
The price of Yahoo! Inc. (Nasdaq:YHOO) stock finished at $37.48, down $0.19 (or -0.50%), and 9,106,691 of its shares exchanged hands on Friday’s trading session
After the closing bell, Bloomberg said that – according to people with knowledge of the matter – tech giant Yahoo! received over 10 initial offers for its core unit ranging between about $4 billion and $8 billion.
Yahoo!, which provides search and display advertising services on Yahoo properties and affiliate sites worldwide, has 946.81M Shares Outstanding, Market Capitalization (intraday) of $35.49B and YHOO stock 52-week range is from $26.15 to $45.10 per share
Shares of Celator Pharmaceuticals, Inc. (Nasdaq:CPXX) surged to touch the $15.90 mark in intraday trading Friday after brokerage firm Stifel initiated coverage on the company’s stock with a Buy rating and a price target of $23.00
CPXX stock closed at $15.73, up $0.21 (or +1.35%), and 2,375,377 of its shares exchanged hnads during the day
Celator Pharmaceuticals, an oncology-focused biopharmaceutical company has 36.39M Shares Outstanding, Market Capitalization (intraday) of $572.35M and CPXX stock one-year range is between $1.12 and $17.40 per share
Disclaimer: The disclaimer is to be read and fully understood before using our site, or joining our email list. GalaxyStocks is not a registered investment adviser. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. Investors should always conduct their own due diligence with any potential investment, with independent research and other professional advice. Read full disclaimer at http://galaxystocks.com/disclaimer/